

"Smart intrauterine sensors monitoring biomarkers to advance fertility treatment and uterine health."
Verso Biosense develops smart intrauterine sensor technology that monitors biomarkers within the uterus to improve clinical understanding of fertility and uterine health. The IRIS platform uses wireless, battery free sensors to measure temperature, dissolved oxygen, and pH continuously, providing healthcare professionals with real time data from an environment that has long remained poorly understood. The technology addresses persistent challenges including unexplained infertility and recurrent implantation failure. By enabling clinicians to better understand the unique conditions into which embryos are transferred, Verso Biosense supports more personalised approaches to IVF and broader diagnostics.


21
Team Members
2015
Founded
Medical Devices
Sector
Hybrid
Work Environment
A future where uterine health is fully understood, fertility treatment is personalised to each woman's unique biology, and conditions affecting millions are diagnosed early and managed effectively.
Verso Biosense exists to advance clinical understanding of the uterine environment through smart sensor technology, enabling healthcare professionals to make evidence based decisions that improve fertility outcomes and women's health.